BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, Liu W, Gao D, Wu Z, Guo S, Wu G, Liu Z, Yu Z, Li L. Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Adv Sci (Weinh) 2020;7:2001936. [PMID: 33101877 DOI: 10.1002/advs.202001936] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Stepanova N. Role of Impaired Oxalate Homeostasis in Cardiovascular Disease in Patients With End-Stage Renal Disease: An Opinion Article. Front Pharmacol 2021;12:692429. [PMID: 34122117 DOI: 10.3389/fphar.2021.692429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhao J, Ning X, Liu B, Dong R, Bai M, Sun S. Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review. Ren Fail 2021;43:102-12. [PMID: 33406960 DOI: 10.1080/0886022X.2020.1864404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Uddin MJ, Farjana M, Moni A, Hossain KS, Hannan MA, Ha H. Prospective Pharmacological Potential of Resveratrol in Delaying Kidney Aging. Int J Mol Sci 2021;22:8258. [PMID: 34361023 DOI: 10.3390/ijms22158258] [Reference Citation Analysis]
4 Huang Y, Xin W, Xiong J, Yao M, Zhang B, Zhao J. The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease. Front Pharmacol 2022;13:837500. [DOI: 10.3389/fphar.2022.837500] [Reference Citation Analysis]
5 Lin S, Zhang T, Zhu L, Pang K, Lu S, Liao X, Ying S, Zhu L, Xu X, Wu J, Wang X. Characteristic dysbiosis in gout and the impact of a uric acid-lowering treatment, febuxostat on the gut microbiota. J Genet Genomics 2021;48:781-91. [PMID: 34509383 DOI: 10.1016/j.jgg.2021.06.009] [Reference Citation Analysis]
6 Kozhieva M, Naumova N, Alikina T, Boyko A, Vlassov V, Kabilov MR. The Core of Gut Life: Firmicutes Profile in Patients with Relapsing-Remitting Multiple Sclerosis. Life (Basel) 2021;11:55. [PMID: 33466726 DOI: 10.3390/life11010055] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Monteiro RC, Berthelot L. Role of gut-kidney axis in renal diseases and IgA nephropathy. Curr Opin Gastroenterol 2021;37:565-71. [PMID: 34482323 DOI: 10.1097/MOG.0000000000000789] [Reference Citation Analysis]
8 Zhang L, Zhang T, Li Y, Xiong W. Shenqi Yanshen Formula (SQYSF) protects against chronic kidney disease by modulating gut microbiota. Bioengineered 2022;13:5625-37. [DOI: 10.1080/21655979.2021.2023789] [Reference Citation Analysis]
9 Mo Y, Sun H, Zhang L, Geng W, Wang L, Zou C, Wu Y, Ji C, Liu X, Lu Z. Microbiome-Metabolomics Analysis Reveals the Protection Mechanism of α-Ketoacid on Adenine-Induced Chronic Kidney Disease in Rats. Front Pharmacol 2021;12:657827. [PMID: 34045965 DOI: 10.3389/fphar.2021.657827] [Reference Citation Analysis]
10 Maier JI, Rogg M, Helmstädter M, Sammarco A, Walz G, Werner M, Schell C. A Novel Model for Nephrotic Syndrome Reveals Associated Dysbiosis of the Gut Microbiome and Extramedullary Hematopoiesis. Cells 2021;10:1509. [PMID: 34203913 DOI: 10.3390/cells10061509] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Zhou Z, Jin H, Ju H, Sun M, Chen H, Li L. Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Front Med 2022;9:828343. [DOI: 10.3389/fmed.2022.828343] [Reference Citation Analysis]
12 Chen TH, Liu CW, Ho YH, Huang CK, Hung CS, Smith BH, Lin JC. Gut Microbiota Composition and Its Metabolites in Different Stages of Chronic Kidney Disease. J Clin Med 2021;10:3881. [PMID: 34501329 DOI: 10.3390/jcm10173881] [Reference Citation Analysis]
13 Ji C, Li Y, Mo Y, Lu Z, Lu F, Lin Q, Liu X, Zou C, Wu Y. Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats. Front Pharmacol 2021;12:780924. [PMID: 34966280 DOI: 10.3389/fphar.2021.780924] [Reference Citation Analysis]
14 Yu M, Li L, Ren Q, Feng H, Tao S, Cheng L, Ma L, Gou S, Fu P. Understanding the Gut-Kidney Axis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: An Analysis of Gut Microbiota Composition. Front Pharmacol 2022;13:783679. [DOI: 10.3389/fphar.2022.783679] [Reference Citation Analysis]
15 Li Z, Chen G, Wang P, Sun M, Zhao J, Li A, Sun Q. Alterations of the Oral Microbiota Profiles in Chinese Patient With Oral Cancer. Front Cell Infect Microbiol 2021;11:780067. [PMID: 34956932 DOI: 10.3389/fcimb.2021.780067] [Reference Citation Analysis]
16 Stepanova N. How Advanced Is Our Understanding of the Role of Intestinal Barrier Dysfunction in the Pathogenesis of Recurrent Urinary Tract Infections. Front Pharmacol 2022;13:780122. [DOI: 10.3389/fphar.2022.780122] [Reference Citation Analysis]
17 Mertowska P, Mertowski S, Wojnicka J, Korona-Głowniak I, Grywalska E, Błażewicz A, Załuska W. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects. Nutrients 2021;13:3637. [PMID: 34684638 DOI: 10.3390/nu13103637] [Reference Citation Analysis]
18 Zhang Q, Zhang Y, Zeng L, Chen G, Zhang, Liu M, Sheng H, Hu X, Su J, Zhang D, Lu F, Liu X, Zhang L. The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease. Front Pharmacol 2021;12:757508. [PMID: 34899312 DOI: 10.3389/fphar.2021.757508] [Reference Citation Analysis]
19 Hsu CN, Yang HW, Hou CY, Chang-Chien GP, Lin S, Tain YL. Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites. Antioxidants (Basel) 2021;10:1211. [PMID: 34439458 DOI: 10.3390/antiox10081211] [Reference Citation Analysis]
20 Liu F, Xu X, Chao L, Chen K, Shao A, Sun D, Hong Y, Hu R, Jiang P, Zhang N, Xiao Y, Yan F, Feng N. Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains. Front Immunol 2021;12:609700. [PMID: 33868230 DOI: 10.3389/fimmu.2021.609700] [Cited by in F6Publishing: 1] [Reference Citation Analysis]